NCT01707966 - Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

July 31, 2016

Conditions

Prostate Cancer

Interventions

DRUG

Orteronel

DRUG

Placebo

Trial Locations (15)

1211

Hôpitaux Universitaires de Genève HUG, Geneva

1708

Kantonsspital Freiburg, Fribourg

3600

SpitalSTS AG Simmental-Thun-Saanenland, Thun

4031

Universitaetsspital Basel, Basel

6000

Kantonsspital Luzern, Lucerne

6500

Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli, Bellinzona

7000

Kantonsspital Graubuenden, Chur

8091

UniversitaetsSpital Zuerich, Zurich

8401

Kantonsspital Winterthur, Winterthur

8596

Kantonsspital Muensterlingen, Münsterlingen

8708

Spital Männedorf, Männedorf

9007

Kantonsspital St. Gallen, Sankt Gallen

CH-5001

Kantonspital Aarau, Aarau

CH-3010

Inselspital Bern, Bern

CH-1011

Centre Hospitalier Universitaire Vaudois CHUV, Lausanne

All Listed Sponsors

lead

Swiss Cancer Institute

OTHER